ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$100.73
*  
3.52
3.62%
Get ALNY Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
3 Potential Game Changers In The Biotech Industry
11/5/2013 4:45:00 PM - Seeking Alpha


Pipeline Progress at Alnylam - Analyst Blog
10/30/2013 4:33:30 PM - Zacks.com


Pipeline Progress at Alnylam - Analyst Blog
10/14/2013 2:46:10 PM - Zacks.com


Rxi Pharmaceuticals Is Undervalued In The RNAi Sector
10/14/2013 9:53:00 AM - Seeking Alpha


Pipeline Update at Alnylam - Analyst Blog
10/8/2013 4:27:32 PM - Zacks.com


Synageva: A Strong Candidate For Your Portfolio
10/8/2013 2:01:00 PM - Seeking Alpha


Alnylam Developing The Next Generation Drug Platform In The $19 Billion Cholesterol Market
10/8/2013 12:32:00 PM - Seeking Alpha


Pipeline Progress at Alnylam - Analyst Blog
10/3/2013 3:30:01 PM - Zacks.com


So You Have Some Questions About Tekmira Pharmaceuticals?
10/1/2013 11:15:00 AM - Seeking Alpha


Alnylam Up on Positive Phase I Data - Analyst Blog
9/24/2013 5:17:51 PM - Zacks.com


Amyloidosis Heats Up On Biotech M&A
9/18/2013 11:40:00 AM - Seeking Alpha


Orphan Drug Status for AEGR's Juxtapid in Japan - Analyst Blog
9/10/2013 10:57:58 AM - Zacks.com


Data Published on Alnylam's ATTR Candidates - Analyst Blog
8/29/2013 3:34:43 PM - Zacks.com


Alnylam Wins Orphan Drug Status - Analyst Blog
8/21/2013 2:20:01 PM - Zacks.com


Good News for Alnylam - Analyst Blog
8/19/2013 6:10:01 PM - Zacks.com


Narrower-than-Expected Q2 Loss at Alnylam - Analyst Blog
8/14/2013 8:35:01 AM - Zacks.com


Aegerion's Lojuxta Gets EU Approval - Analyst Blog
8/5/2013 4:20:01 PM - Zacks.com


Best Stocks: Isis, Gilead, Celgene, and Regeneron Take Over the Top Ranks
7/29/2013 8:20:00 AM - Minyanville


Alnylam Targets New Highs On Data Supporting RNAi
7/19/2013 6:14:00 PM - Seeking Alpha


Putting Alnylam's Positive ATTR Clinical Data In Context
7/19/2013 1:28:00 PM - Seeking Alpha


Market Wrap for Friday, July 12: Stocks Rise as S&P 500 Closes At New All-Time High
7/12/2013 3:45:17 PM - Benzinga


A Great Day And A Great Future For Alnylam
7/12/2013 11:45:00 AM - Seeking Alpha


Northera NDA Resubmitted By Chelsea - Analyst Blog
7/11/2013 5:56:18 PM - Zacks.com


Market Wrap for Thursday, July 11: Market Jumps on Dovish Bernanke Comments
7/11/2013 3:14:45 PM - Benzinga


Australian Approval for Vertex' Kalydeco - Analyst Blog
7/10/2013 10:40:01 AM - Zacks.com